Volume 21, Issue 2 pp. 169-170
Mutation in Brief
Free Access

Phenotypic cellular characterization of an Ataxia telangiectasia patient carrying a causal homozygous missense mutation

Sandra Angèle

Sandra Angèle

DNA Repair Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

Search for more papers by this author
Anthony Laugé

Anthony Laugé

Unitéde Génétique Oncologique, Institut Curie, 26 rue d'Ulm, 75231 Paris Cedex 05, France

Search for more papers by this author
Marie Fernet

Marie Fernet

DNA Repair Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

Search for more papers by this author
Norman Moullan

Norman Moullan

DNA Repair Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

Search for more papers by this author
Pierre Beauvais

Pierre Beauvais

Service de Neuropédiatrie, Hopital Trousseau, Paris, France

Search for more papers by this author
Jérôme Couturier

Jérôme Couturier

Unitéde Génétique Oncologique, Institut Curie, 26 rue d'Ulm, 75231 Paris Cedex 05, France

Search for more papers by this author
Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Unitéde Génétique Oncologique, Institut Curie, 26 rue d'Ulm, 75231 Paris Cedex 05, France

Search for more papers by this author
Janet Hall

Corresponding Author

Janet Hall

DNA Repair Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

DNA Repair Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, FranceSearch for more papers by this author
First published: 27 January 2003
Citations: 18

Communicated by Mark H. Paalman

Online Citation: Human Mutation, Mutation in Brief #578 (2003) Online http://www.interscience.wiley.com/humanmutation/pdf/mutation/578.pdf

Abstract

Most disease-causing mutations in Ataxia telangiectasia (AT) patients correspond to truncating mutations in the ATM gene with very few cases of AT patients carrying two missense sequence alterations being reported. The cellular phenotype of a lymphoblastoid cell line established from an AT patient (AT173) who showed classical clinical AT features, and carried two homozygous missense alterations, the 378T>A variant and 9022C>T located within the ATM kinase domain, has been characterized. ATM mRNA was detectable and the ATM protein level was approximately 50% of that seen in normal cell lines. Functional analysis of this protein revealed a total absence of ATM kinase activity measured either in vitro or in vivo, before and after exposure to ionizing radiation. The AT173 cell line was hypersensitive to ionizing radiation and exhibited a G1 cell cycle arrest defect and an accumulation of cells in G2 phase of the cell cycle after irradiation, a response that is identical to that seen in AT cell lines carrying truncating mutations. These phenotypic features strongly suggest that the 9022C>T (R3008C) missense mutation is the disease-causing mutation and that the presence of ATM protein is not always predictive of a normal cellular phenotype. © 2003 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.